Botwood Nicholas A.J.
- SEC CIK
- 0002066784
In the past year, 1 open-market sale filing worth $1.18M and no purchases.
Current role at each company
- SNDX Syndax Pharmaceuticals IncHead of R&D, CMOas of Jun 12, 2026
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- $1.18M
- 1 filing
- Net
- −$1.18M
- Bought minus sold
- Companies
- 1
- With open-market trades
Trades
Every Form 4 that lists Botwood Nicholas A.J. as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Jun 12, 2026 (view filing) | Jun 11-12 | 1 day | Botwood Nicholas A.J.Head of R&D, CMO | SSale | −65.5K | $18.07 | −$1.18M | −51.8%60.9K after | 2 lots10b5-1 |
| May 19, 2025 (view filing) | May 16 | 3 days | Botwood Nicholas A.J.Head of R&D, CMO | PPurchase | +11.8K | $9.00 | +$105.9K | +50.3%35.2K after |